Study author David Brousseau, MD, MS, explains the benefit of a child being able to go home after a sickle cell disease-associated ED visit.
David Brousseau, MD, MS
Advertisement
David Brousseau, MD, MS, Pediatrician-in-chief, director of Research, Nemours Children’s Health
Articles by David Brousseau, MD, MS
Brousseau stressed that timeliness is not just guideline adherence, but it meaningfully changed whether children can go home from the ED, according to study results.
Advertisement
Latest Updated Articles
David Brousseau, MD, highlights impact of timely opioid dosing in pediatric sickle cell painPublished: September 5th 2025 | Updated:
- David Brousseau, MD: Benefits of timely opioid dosing for SCD pain
Published: September 12th 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Recurrent nausea and vomiting in an 18-year-old
2
Is shortened treatment for urinary tract infections a good idea?
3
Dupilumab's continued efficacy in pediatric EoE patients, with Joshua Wechsler, MD
4
Do not underestimate the value of physical examination
5
